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High-sensitivity C-reactive Protein is a Predictive Factor of Adiposity in
Children: Results of the Identiﬁcation and prevention of Dietary- and
lifestyle-induced health Effects in Children and InfantS (IDEFICS) Study
Annunziata Nappo, BSc; Licia Iacoviello, MD, PhD; Arno Fraterman, MSc; Esther M. Gonzalez-Gil; Charis Hadjigeorgiou, MD;
Staffan Marild, MD, PhD; Denes Molnar, MD; Luis A. Moreno, MD, PhD; Jenny Peplies, MSc; Isabel Sioen, PhD;
Toomas Veidebaum, PhD; Alfonso Siani, MD; Paola Russo, BSc
Background-—Whereas cross-sectional studies have shown that obesity is associated with increased C-reactive protein (CRP)
levels in children, little is known about the impact of low-grade inﬂammation on body mass changes during growth.
Methods and Results-—We assessed cross-sectionally and longitudinally the association of high-sensitivity (hs)-CRP levels with
overweight/obesity and related cardiometabolic risk factors in the Identiﬁcation and prevention of Dietary- and lifestyle-induced
health Effects in Children and InfantS (IDEFICS) cohort. 16 224 children from 8 European countries (2 to 9 years) were recruited
during the baseline survey (T0). After the exclusion of 7187 children because of missing hs-CRP measurements and 2421 because
of drug use during the previous week, the analysis was performed on 6616 children (Boys=3347; Girls=3269; age=6.31.7 years).
Of them, 4110 were reexamined 2 years later (T1). Anthropometric variables, blood pressure, hs-CRP, blood lipids, glucose and
insulin were measured. The population at T0 was divided into 3 categories, according to the baseline hs-CRP levels. Higher hs-CRP
levels were associated with signiﬁcantly higher prevalence of overweight/obesity, body mass index (BMI) z-score and central
adiposity indices (P values all <0.0001), and with higher blood pressure and lower HDL-cholesterol levels. Over the 2-year follow-
up, higher baseline hs-CRP levels were associated with a signiﬁcant increase in BMI z-score (P<0.001) and signiﬁcantly higher risk
of incident overweight/obesity.
Conclusions-—Higher hs-CRP levels are associated to higher body mass and overweight/obesity risk in a large population
of European children. Children with higher baseline levels of hs-CRP had a greater increase in BMI z-score and central
adiposity over time and were at higher risk of developing overweight/obesity during growth. ( J Am Heart Assoc. 2013;2:
e000101 doi: 10.1161/JAHA.113.000101)
Key Words: C-reactive protein • inﬂammation • pediatric obesity • population
T he role of chronic low-grade inﬂammation as a possiblelink between obesity and its metabolic and cardiovas-
cular sequelae has been convincingly showed during the last
years.1
C-reactive protein (CRP) has long been considered a
prototypic biomarker of subclinical inﬂammation.2 Since
analytical standards were deﬁned for its measurement,3 the
high-sensitivity CRP (hs-CRP) assay is considered a sensitive
predictor of atherosclerosis, diabetes and coronary heart
diseases also in apparently healthy individuals.4–7
About 10 years ago, large epidemiological studies unequiv-
ocally showed the association of low-grade inﬂammation and
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overweight in children.8–10 The number of studies exploring
different aspects of this association has been steadily
increasing in the last years, as recently reviewed by Tam
et al.11
The summary evidence from previous studies is that a
consistent association exists between obesity and increased
CRP levels in children. However, since most of the information
derives from cross-sectional investigations, there is a need to
conﬁrm this association in longitudinal studies, aiming to
conﬁrm the value of hs-CRP as an early-detectable surrogate
marker in the natural history of the association between
childhood obesity and cardiovascular disease late in adulthood.
The aim of the present study was to assess cross-
sectionally and longitudinally the association of hs-CRP levels
with overweight/obesity and related cardiometabolic risk
factors in a large sample of European preschool and primary
school children participating in the IDEFICS project. The
2-year follow-up of the Identiﬁcation and prevention of Dietary-
and lifestyle-induced health Effects in Children and InfantS
(IDEFICS) cohort allowed to test whether higher baseline levels
of hs-CRP were associated with higher body mass and
increased incidence of overweight/obesity over time.
Materials and Methods
Ethics Statement
The study was conducted according to the standards of the
Declaration of Helsinki. All applicable institutional and
governmental regulations pertaining to the ethical use of
human volunteers were followed during this research.
Approval by the appropriate ethics committees was obtained
by each of the 8 participating centers carrying out the
ﬁeldwork. Participants were not subjected to any study
procedure before both the children and their parents gave
their oral (children) and written (parents) informed consent for
examinations, collection of samples, subsequent analysis and
storage of personal data and collected samples.
Study Population
IDEFICS is a large European multicenter study of childhood
obesity. Details of the general design, instruments and survey
characteristics can be found elsewhere.12
A cohort of 16 224 children aged 2 to 9 years was
recruited into a population-based baseline survey from 8
European countries ranging from the north to the south and
from the east to the west (Belgium, Cyprus, Estonia, Germany,
Hungary, Italy, Spain, and Sweden). The baseline survey (T0)
was the starting point of the cohort study aimed to
prospectively evaluate the role of the factors assessed at
baseline on the development of overweight/obesity over time,
and to assess the feasibility, effectiveness, and sustainability
of a community-oriented intervention program. Comparable
intervention and control regions were selected in each
country. In the intervention regions, a coherent set of
intervention modules were implemented, focusing on diet,
physical activity, and stress-coping capacity. All the materials
for the interventions were centrally developed and culturally
adapted. A detailed description of the IDEFICS intervention
program has been recently published.13
A second survey (T1) reassessed the children 2 years later.
The follow-up survey was synchronized with the baseline to
account as much as possible for seasonal variation. In fact,
the study protocol, closely followed by each survey center,
allowed for a 2-year period (1 month) between T0 and T1.
Of the 16 224 children examined at T0, 7187 children were
excluded from the present analysis. In particular, 4766 children
had no hs-CRP measured (Boys=50%; age=5.8 1.8 years;
meanSD) and 2421 children (Boys=53%; age=5.91.8 years)
were excluded because of the use of medications during the
week previous to the visit. Eventually, the cross-sectional
analysis was carried out in 6616 children (Boys=50%;
age=6.31.7 years). Excluded children were signiﬁcantly
younger than those included (P<0.001), likely due to the lower
acceptance of blood drawing in younger children, while
anthropometric parameters were not statistically signiﬁcant
different between the 2 groups (data not shown).
Of these 6616 children, 4110 were re-examined 2 years
later (T1) (Boys=51%; age=8.21.7 years, control group
n=1960, intervention n=2150). The distribution of children
in the control and intervention region was balanced across the
baseline hs-CRP categories. Since no statistically signiﬁcant
differences in the anthropometric outcomes were observed
between children in the intervention and in the control
regions, longitudinal analyses were performed on the whole
T1 population sample.
Anthropometry and Blood Pressure
Children underwent a standardized physical examination.
Anthropometric data included body weight and height, waist
and hip circumferences, and the measurement of skinfold
thickness. A detailed description of the anthropometric
measurements in the IDEFICS study, including intra- and
interobserver reliability, has been recently published.14
The measurement of weight was carried out using an
electronic scale (Tanita BC 420 SMA, Tanita Europe GmbH) to
the nearest 0.1 kg with children wearing light clothes without
shoes. Height was measured using a telescopic height-
measuring instrument (Seca 225 stadiometer) to the nearest
0.1 cm. Body mass index (BMI) was calculated as weight (in
kg) divided by height squared (in m). For each child, z-scores
of BMI and of BMI variation over the 2-year follow-up were
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determined according to the sex- and age-speciﬁc z-scores by
Cole et al.15
Waist circumference was measured using an inelastic tape
(Seca 200), precision 0.1 cm, range 0150 cm at the
midpoint between the iliac crest and the lower border or
tenth rib with the subject in a standing position and recorded
at the nearest 0.1 cm. Both triceps and subscapular skinfold
thickness were measured by means of a caliper (Holtain,
Holtain Ltd, range 040 mm). Measures were taken twice on
the right hand side of the body and the mean was calculated.
For the deﬁnition of overweight/obesity, children were
grouped into 2 categories using the cut-points deﬁned by Cole
et al16,17: (1) underweight (thinness grade III to I) plus normal
weight and (2) overweight plus obese.
Systolic and diastolic blood pressure (BP) was measured
after 5 minutes rest in the seated position, at the child right
arm with a cuff of appropriate size for arm circumference
using an automatic sphygmomanometer (Welch Allyn
4200B-E2 Inc.). Two measurements were made and the
average of the measurements was used for analysis.
Biochemistry
Children were asked to participate, on voluntary basis, in
blood drawing. A detailed description of sample collection and
analytical procedures in the IDEFICS survey has been recently
published.18,19
CRP levels were measured in a central laboratory with a
high-sensitivity assay using latex-enhanced nephelometry
(BN2-Nephelometer, Siemens), The lower limit of detection
of the assay was 0.02 mg/dL.
Blood glucose, total- and HDL-cholesterol, and triglycerides
were assessed, in fasting status by the portable Cholestech
LDX analyzer at each point-of-care center.20 LDL-cholesterol
was calculated according to the formula of Friedwald.21
Serum insulin and glycated hemoglobin (HbA1c) were
measured in a central laboratory through enzyme-linked
immunosorbent assay kit (MODULAR E170, Roche Diagnos-
tics) and by high-pressure liquid chromatography with an
automated HLC-723G7 analyzer respectively. Homeostatic
model assessment (HOMA) index was calculated according to
the formula: HOMA = [serum insulin (lU/mL) 9 blood glucose
(mmol/L)]/22.5.22 Categories of “insulin-resistant” children
were deﬁned by the 75th percentile of HOMA index for boys
(normal, HOMA index≤1.16, high >1.16) and girls (normal,
HOMA index≤1.24, high >1.24).
Questionnaire
Parents were asked to ﬁll in a questionnaire to collect data on
the participating child (date of birth, weight and length at birth,
physical activity and lifestyle factors, personal and familial
medical history). Parental information was collected as well
(age, self-reported weight and height, education level, and
occupation). With regard to physical activity, parents were
invited to indicate howmanyminutes per day their child used to
spend in outdoor activities (ie, time spent playing in the yard or
street around house or outdoor recreation area [swimming pool,
zoo, park] either on week days or weekend days). An additional
question investigated whether or not the child would have
attended a club to practice sport. The total weekly physical
activity time was calculated as the sum of the number of hours
spent in each activity category. Educational level of the parents
was estimated by International Standard Classiﬁcation of
Education (ISCED) criteria 23 in 6 categories (from 0 to 5).
Parents were considered overweight if their self-reported BMI
was ≥25 kg/m2. Breastfeeding was classiﬁed as: none; 0 to 3
months; 3 to 6 months; >6 months. Parents were also asked to
indicate whether their child had taken any kind of medication,
including self-prescribed drugs, vitamin, and mineral supple-
ments, during the week before blood sample drawing.
Statistical Analysis
Statistical analyses were performed using PASW (Predictive
Analytics SoftWare) Statistics (version 18; SPSS Inc.). The
analyses were performed separately in boys and girls. Data
are presented as mean (95% conﬁdence intervals) or median
and range, as indicated. Categorical variables are shown as
absolute frequencies. Given that the distribution of hs-CRP
was skewed, log-transformed values were used for statistical
analysis. For ease of interpretation, untransformed values are
presented. Because about 50% of children had values less
than the minimal detectable concentration, in this analysis
hs-CRP is treated as a categorical rather than as a continuous
variable. The following 3 hs-CRP cut–offs were arbitrarily
deﬁned to categorize hs-CRP levels in our population: (I) hs-CRP
under the detection limit (<0.02 mg/dL); (II) hs-CRP>
0.02 mg/dL and <75th sex-speciﬁc percentile of those with
hs-CRP values over the detection limit (<0.177 mg/dL in boys
and 0.180 mg/dL in girls) (III) hs-CRP>75th sex-speciﬁc
percentile of those with hs-CRP values over the detection limit
(>0.177 mg/dL in boys and >0.180 mg/dL in girls). Preva-
lence of overweight/obesity across hs-CRP categories was
tested by linear by linear association chi-square test statistics.
Multiple linear regression analysis (GLM) was used to
compare mean values of outcome variables across categories
of hs-CRP. P values for linear trend were calculated. All
analyses were adjusted for child age, country of origin, breast-
feeding, physical activity, parental overweight/obesity (none
or at least one affected parent), and parental education. BP
and metabolic variables were also adjusted for BMI.
Longitudinal analyses were performed using the 2-year
variation in the outcome adiposity variables (follow-up, T1
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minus baseline, T0) across the baseline hs-CRP categories, by
multiple linear regression analysis adjusted for the respective
baseline value of the outcome variable and for other relevant
confounders (age, country of origin, physical activity, parental
overweight and obesity, breast-feeding, parental education,
intervention/control study group). P values for linear trend
were calculated. Incident cases of overweight/obesity over
the 2-year follow-up according to hs-CRP groups at baseline
were assessed by logistic regression analysis, taking into
account age, country of origin, and intervention/control study
group. Odds ratio and their 95% conﬁdence intervals were
calculated. A 2-tailed P value less than 0.05 was considered
statistically signiﬁcant.
Results
Cross-sectional Analysis
Baseline anthropometric and metabolic characteristics of the
male and female participants are summarized in Table 1.
Hs-CRP levels ranged between 0.02 mg/dL (detection limit)
and 8.50 mg/dL in boys and 9.35 mg/dL in girls, respectively.
Table 2 shows the anthropometric and metabolic variables
at baseline (T0) according to the 3 categories of hs-CRP in
boys and girls. The prevalence of overweight/obesity signif-
icantly increased across the categories of hs-CRP in both
sexes (Table 2). At multiple regression analysis, adjusted for
age, country of origin, breast-feeding, physical activity,
parental overweight/obesity, and parental education, a linear
highly signiﬁcant increase in BMI z-score, waist circumfer-
ence, and sum of skinfolds was observed both in boys and in
girls, moving across the categories of hs-CRP.
After adjustment for BMI, a signiﬁcant increase in diastolic
blood pressure was observed in both sexes, while higher
systolic blood pressure values in the higher hs-CRP categories
were observed only in boys. In both sexes higher values of
hs-CRP were associated with lower total cholesterol and HDL-
cholesterol levels. The ratio between total and HDL-choles-
terol was signiﬁcantly higher in girls with higher hs-CRP levels.
Indices of glucose status/insulin-resistance did not vary
across hs-CRP categories in both sexes, but for the lower
plasma glucose levels observed in the boys with higher
hs-CRP values. At categorical analysis, the proportion of
children with higher insulin resistance (HOMA index > 75th
percentile of the distribution for boys and girls respectively)
did not differ across the categories of hs-CRP.
Prospective Analysis
Among the 6616 children examined at T0, 4110 were
reexamined 2 years later (T1) (62% of the T0 sample). Table 3
shows the prevalence of overweight/obesity and the adjusted
changes in anthropometric variables over the 2-year follow-up
across the hs-CRP categories assessed at baseline (T0). In
both boys and girls, over the 2-year follow-up, participants
with higher baseline hs-CRP levels showed signiﬁcantly higher
increase in BMI z-score and indices of central adiposity, after
adjustment for the respective baseline value and indepen-
dently of the study group (control versus intervention). The
highly signiﬁcant statistical association between baseline
hs-CRP values and the variation of BMI over the 2-year
follow-up was indeed not affected by the intervention (P for
trend: boys, unadjusted=0.000066; adjusted=0.000062; girls,
unadjusted=0.001; adjusted=0.001).
Out of 4110 children reexamined at T1, 1951 boys and
1819 girls were not overweight/obese at baseline (T0).
After the 2-year follow-up, 179 incident cases of overweight/
obesity were observed in boys and 137 in girls. At logistic
regression analysisadjusted for age, country of origin,
physical activity, parental overweight and obesity, breast-
feeding, parental education, and intervention/control study
groupthe risk to become overweight/obese, according to
the baseline hs-CRP levels, increased signiﬁcantly across the
hs-CRP categories (Table 4).
Table 1. Characteristics of the Study Subjects by Sex
Boys (n=3347) Girls (n=3269)
Age, y 6.221.76 6.311.73
BMI, kg/m2 16.452.50 16.452.49
BMI z-score 0.261.31 0.241.38
Sum of skinfolds,
mm
17.177.58 19.958.11
Waist circumference,
cm
54.927.06 54.436.93
SBP, mm Hg 100.69.2 100.49.2
DBP, mm Hg 62.66.6 63.46.5
Glucose, mmol/L 4.720.54 4.620.52
HbA1c, % 4.670.56 4.610.58
Insulin, pmol/L 28.8924.64
(n=2905)
33.2027.39
(n=2777)
HOMA-Index 0.900.83
(n=2732)
1.000.87
(n=2592)
TG, mmol/L 0.480.27 0.500.28
Total Cholesterol,
mmol/L
4.100.76 4.220.82
HDL-Cholesterol,
mmol/L
1.390.37 1.350.37
hs-CRP (mg/dL),
median (range)
0.03 (0.02 to 8.50) 0.04 (0.02 to 9.35)
Values are meanstandard deviation or median and range. BMI indicates body mass
index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycosylated
hemoglobin A 1c; HOMA, Homeostatic model assessment; TG, triglycerides; HDL, high-
density lipoprotein, hs-CRP, high sensitivity C-reactive protein.
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Discussion
The current study evaluated the association between hs-CRP
levels, adiposity indices and cardiometabolic abnormalities in
the preschool and primary school children participating in the
European IDEFICS cohort. The longitudinal evaluation allowed
the current study to focus on the predictive value of baseline
hs-CRP levels on the changes in anthropometric parameters
and on the development of overweight/obesity over the 2-year
follow-up. Cross-sectional analyses revealed that boys and girls
with higher plasma concentrations of hs-CRP at baseline
present (1) higher BMI z-scores and central fat deposition;
(2) higher prevalence of overweight/obesity; (3) higher
BMI-adjusted BP and lower BMI-adjusted HDL-cholesterol
levels, with a signiﬁcantly worse ratio between total and
HDL-cholesterol in girls. Longitudinal analyses showed that
higher plasma concentrations of hs-CRP at baseline predict (1)
a higher increase of BMI z-scores and central adiposity indexes
over the 2-year follow-up, and (2) a signiﬁcantly higher risk of
incident overweight/obesity in both boys and girls.
Our data showed a strong correlation between adiposity
indices and hs-CRP in children. This correlation was similar to
other studies where plasma hs-CRP levels were positively
associated with adiposity in adults 24–26 and children.8–10, 27
In our study, cross-sectional analyses also showed that higher
hs-CRP values are associated with cardiovascular risk factors,
like higher BP and lower HDL-cholesterol levels. Previous
studies already suggested that high CRP levels in children are
associated with cardiovascular risk factors including HDL-
cholesterol and BP,8, 28, 29 although in some studies the
association did not survive after adjustment for body
mass.29,30 In our study, the low-grade proinﬂammatory status
consistent with higher hs-CRP levels is associated to a worse
atherogenic proﬁle already in preschool and school children,
independently from body mass. The ﬁnding is of interest
because the low-grade inﬂammation has been found to
predict the development of CVD 31 and type 2 diabetes.6Ta
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Table 4. Odds Ratio to Develop Overweight/Obesity Over
the 2-year Follow-Up by hs-CRP Categories Deﬁned at
Baseline (T0)
Boys (n=1952) Girls (n=1819)
OR (95% CI) P Value OR (95% CI) P Value
I 1 — — 1 — —
II 2.0 (1.4;2.9) <0.001 2.0 (1.2;3.2) 0.004
III 2.0 (1.1;3.5) 0.022 2.6 (1.4;4.7) 0.002
Overweight/obesity deﬁned according to International Obesity Task Force age- and sex-
speciﬁc cut-off. Logistic regression analysis adjusted for age, country of origin, physical
activity, parental overweight and obesity, breast-feeding, parental education, and
intervention/control study group. OR indicates odds ratio; CI, conﬁdence interval.
hs-CRP value: Boys I: <0.020 mg/dL; II: >0.020<0.177 mg/dL; III: >0.177 mg/dL—
Girls I: <0.020 mg/dL; II: >0.020<0.180 mg/dL; III: >0.180 mg/dL.
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With regard to insulin resistance, Shea et al32 and Moran
et al33 provided evidence of an association of CRP levels with
insulin resistance markers in children, although no longer
signiﬁcant after adjustment for adiposity in the study by
Moran.33 In our study we did not observe differences in insulin
resistance measures between the different groups of hs-CRP,
probably due to the fact that our cohort is on average too
young for detecting some metabolic derangements that might
occur more likely later with age.34,35 In fact, the International
Diabetes Federation and the American Heart Association have
both proposed a deﬁnition of metabolic syndrome in children
and adolescents.34,35 In both guidelines, the cut-offs for
metabolic and BP variables were deﬁned only for children
above 10 years of age, due to the high variability of these
variables below this age. It is thus possible that the
association would be more evident during adolescence rather
than childhood. Long-term prospective studies, as the ongo-
ing follow-up of the IDEFICS cohort, are needed to answer this
question.
A strength of the present study is the use of precisely
standardized phenotypic measurements within the 8 Euro-
pean countries participating in the survey. In fact, all
measurements were conducted according to detailed stan-
dard operation procedures. In particular, subsamples of study
subjects were examined repeatedly to calculate the inter- and
intraobserver reliability of anthropometric measurements.14
The primary limitation is the use of a single hs-CRP
measurement. In adults, repeat hs-CRP measurements are
recommended, as concentrations are affected by factors such
as recent infection and inﬂammatory conditions. The mea-
surement of other inﬂammatory biomarkers could have
provided further insights on the early association between
inﬂammation and body fat accumulation. Other tests for
active infection, for example cytokines or white blood cell
count, were not performed, although the exclusion from the
analysis of children who took medications during the week
before the blood drawing may be considered as an adequate
proxy. The assessment of the parental smoking and the
consequent secondary smoking exposure of children would
have been of interest, but unfortunately these questions were
not included in the IDEFICS questionnaire. A limitation of the
longitudinal analysis is the lower number of children attending
the follow-up examination and the relatively short duration of
the follow-up. However, the longitudinal association of basal
hs-CRP values with adiposity indices and incidence of
overweight/obesity clearly emerged even after the relatively
short follow-up period and notwithstanding the expected
reduction of the sample size, mainly due to the burden of the
extensive examination protocol. The comparability of the core
measurements between the children retained and those lost
at follow-up makes us conﬁdent that selection bias did not
affect the longitudinal results. The planned follow-up of the
IDEFICS cohort in subsequent years will allow further
evaluation of the association of hs-CRP with body mass and
metabolic variables during the transition from childhood to
adolescence. Finally, the possibility that the intervention
program conducted in half of the population could have
marginally affected the relationship between the baseline
hs-CRP values and the phenotypes of interest over the follow-
up cannot be excluded. This possibility was taken into
account by adjusting for the control/intervention group in the
longitudinal analysis. In summary, we conﬁrmed the associ-
ation between hs-CRP and higher body mass and overweight/
obesity risk in a large population of European children. We
also showed that hs-CRP levels are associated to a worse
cardiovascular risk proﬁle. The main and novel ﬁnding of the
study is that the children with higher baseline level of hs-CRP
had a greater increase in body mass and central adiposity
over time and therefore were at higher risk of developing
overweight/obesity during growth, as compared with children
less exposed to low-grade inﬂammation.
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